Rigsby Rigsby

Health and Research – Alzheimer's/Dementia

FDA Approves Biogen’s Aduhelm, the First New Drug for Alzheimer’s Disease Since 2003

Today marks an important milestone in Alzheimer’s disease research with the approval by the FDA…

Rigsby RigsbyOctober 27, 2021

Health and Research – Alzheimer's/Dementia

Progress in Alzheimer’s Disease Builds Renewed Interest in Research

In June of 2021, the FDA approved a new drug, Aduhelm, from the company Biogen…

Rigsby RigsbyOctober 27, 2021

Health and Research – Behavior

Regression in Persons with Down Syndrome: Current Consensus Update for Families

Regression is a term for the loss of previously acquired developmental skills in an individual.…

Rigsby RigsbyOctober 21, 2021

Health and Research – Alzheimer's/Dementia

Biomarkers and Therapeutics for People with Down Syndrome and Alzheimer’s Disease

The NTG brought together a national panel of expert researchers and practitioners in the field…

Rigsby RigsbyOctober 20, 2021

Health and Research – Other

Tips for Dealing with Stress Handout

This handout gives suggestions for ways to manage stress. It corresponds to the Tips for…

Rigsby RigsbyOctober 19, 2021

Health and Research – Alzheimer's/Dementia

A New Perspective on The Aduhelm Controversy

In June, the FDA granted “accelerated approval” to Biogen’s Aduhelm drug. This is the first…

Rigsby RigsbyOctober 15, 2021

Health and Research – Other

Questions to Ask When Prescribed a New Medication

Are you a person with Down syndrome and you are being prescribed a new medication?…

Rigsby RigsbyOctober 6, 2021

Health and Research – Behavior Health and Research - COVID-19

Possible Causes of Regression in People with Down Syndrome During the COVID-19 Pandemic

We received a question about a man with Down syndrome in his late 30s. His…

Rigsby RigsbyOctober 6, 2021

Health and Research – Other

Bereavement

People with and without Down syndrome experience grief and sadness when a loved one dies.…

Rigsby RigsbyOctober 6, 2021

Health and Research – Other

Gout in People with Down Syndrome

Gout is more common in people with Down syndrome (DS), as indicated by the study…

Rigsby RigsbyOctober 6, 2021

FDA Approves Biogen’s Aduhelm, the First New Drug for Alzheimer’s Disease Since 2003

Progress in Alzheimer’s Disease Builds Renewed Interest in Research

Regression in Persons with Down Syndrome: Current Consensus Update for Families

Biomarkers and Therapeutics for People with Down Syndrome and Alzheimer’s Disease

Tips for Dealing with Stress Handout

A New Perspective on The Aduhelm Controversy

Questions to Ask When Prescribed a New Medication

Possible Causes of Regression in People with Down Syndrome During the COVID-19 Pandemic

Bereavement

Gout in People with Down Syndrome

CONTACT LUMIND IDSC

QUICK LINKS

JOIN US